Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fever × Dermatologic × Clear all

Phase

Phase 3 4 Phase NA 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Lymphoid 2 Classical hematology 2 Sarcoma 1 NET 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Endocrine 1 Dermatologic 1 Breast 1

Conditions

Melanoma 732 Lymphoma, T-Cell, Cutaneous 119 Uveal Melanoma 83 Skin Neoplasms 83 Mycosis Fungoides 78 Sezary Syndrome 65 Neoplasm Metastasis 57 Lymphoma 56 Keratosis, Actinic 56 Carcinoma, Basal Cell 54 Lymphoma, Non-Hodgkin 53 Neoplasms 51 Leukemia, Lymphocytic, Chronic, B-Cell 47 Carcinoma, Renal Cell 47 Carcinoma, Non-Small-Cell Lung 45 Lymphoma, B-Cell, Marginal Zone 44 Precursor Cell Lymphoblastic Leukemia-Lymphoma 43 Lymphoma, Mantle-Cell 43 Lymphoma, Large B-Cell, Diffuse 43 Lymphoma, Follicular 43 Hodgkin Disease 42 Carcinoma, Merkel Cell 42 Lymphoma, Large-Cell, Immunoblastic 41 Burkitt Lymphoma 41 Brain Neoplasms 37 Multiple Myeloma 36 Breast Neoplasms 34 Leukemia, Myeloid, Acute 33 Recurrence 32 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡